Sector
PharmaceuticalsOpen
₹911.2Prev. Close
₹911.2Turnover(Lac.)
₹2,636Day's High
₹918.35Day's Low
₹857.452 Week's High
₹97152 Week's Low
₹557.05Book Value
₹207.3Face Value
₹5Mkt Cap (₹ Cr.)
7,830.83P/E
30.49EPS
28.39Divi. Yield
0.585 Feb 2025
12:00 AM
Dividend
Dividend Amount: 2.5
Record Date: 14 Feb, 2025
25 Apr 2025
12:00 AM
Board Meeting
Agenda : Audited Result
15 Jul 2024
12:00 AM
AGM
Announcement Date: 15 Jul, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 45.31 | 45.31 | 45.56 | 0.25 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,576.15 | 1,393.27 | 1,238.71 | -0.02 |
Net Worth | 1,621.46 | 1,438.58 | 1,284.27 | 0.23 |
Minority Interest |
No Record Found
No Record Found
No Record Found
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 2,115.07 | 1,852.61 | 1,945.23 | 1,199.94 | 0 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 2,115.07 | 1,852.61 | 1,945.23 | 1,199.94 | 0 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 10.12 | 4.9 | 2.32 | 2.51 | 0 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,706.7 | 95.71 | 4,09,218.58 | 753.53 | 0.94 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,595.5 | 79.35 | 1,75,226.52 | 667 | 0.45 | 2,536 | 561.08 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,741.9 | 63.7 | 1,26,637.21 | 551 | 0.16 | 2,567 | 224.34 |
Cipla Ltd CIPLA | 1,554.6 | 24.3 | 1,25,540.69 | 1,303.13 | 1.03 | 4,501.66 | 397.39 |
Dr Reddys Laboratories Ltd DRREDDY | 1,270.3 | 15.39 | 1,06,062.83 | 2,961.2 | 0.63 | 7,788.7 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
Rashesh C Gogri
Vice Chairperson & Managing Director
Hetal Gogri Gala
Managing Director
Narendra Jagannath Salvi
Non Executive Director
Rajendra V Gogri
Non Executive Director
Parimal H Desai
Independent Director
Bhavesh R Vora
Independent Director
Vinay Gopal Nayak
Independent Director
Vilas G Gaikar
Independent Director
Jeenal Savla
Independent Director
Rupal Vora
Independent Director
Pradeep Thakur
Company Sec. & Compli. Officer
Jeevan Mondkar
Chairman Emeritus
C V Gogri
Non Executive Director
NEHAL GAREWAL
Plot No 22/C/1 & 22/C/2,
1st Phase GIDC Vapi,
Gujarat - 396195
Tel: 91-22-6797 6666
Website: https://www.aartipharmalabs.com
Email: co.apl@aartipharmalabs.com ; investorrelations@aar
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Aarti Pharmachem Limited, formerly known as Aarti Organics Limited, was incorporated as a Public Limited Company in 2019. The Company changed the name from Aarti Organics Limited to Aarti Pharmachem L...
Read More
Reports by Aarti Pharmalabs Ltd
What is the Aarti Pharmalabs Ltd share price today?
What is the Market Cap of Aarti Pharmalabs Ltd?
What is the PE and PB ratio of Aarti Pharmalabs Ltd?
What is the 52 Week High and Low of Aarti Pharmalabs Ltd?
What is the CAGR of Aarti Pharmalabs Ltd?
What is the shareholding pattern of Aarti Pharmalabs Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.